Item 7.01 Regulation FD Disclosure.

On November 16, 2021, Adagio Therapeutics, Inc. (the "Company") posted a corporate presentation on the Company's website, which the Company may use from time to time in conversations with investors, analysts or other third parties. A copy of the presentation may be found on the Company's website at https://investors.adagiotx.com/news-events/events-presentations.

The information in this Item 7.01 is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses